Diagnosis and management in Pitt-Hopkins syndrome: First international consensus statement.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
04 2019
Historique:
received: 19 11 2018
revised: 20 12 2018
accepted: 09 01 2019
pubmed: 25 1 2019
medline: 19 5 2020
entrez: 25 1 2019
Statut: ppublish

Résumé

Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental disorder characterized by intellectual disability, specific facial features, and marked autonomic nervous system dysfunction, especially with disturbances of regulating respiration and intestinal mobility. It is caused by variants in the transcription factor TCF4. Heterogeneity in the clinical and molecular diagnostic criteria and care practices has prompted a group of international experts to establish guidelines for diagnostics and care. For issues, for which there was limited information available in international literature, we collaborated with national support groups and the participants of a syndrome specific international conference to obtain further information. Here, we discuss the resultant consensus, including the clinical definition of PTHS and a molecular diagnostic pathway. Recommendations for managing particular health problems such as dysregulated respiration are provided. We emphasize the need for integration of care for physical and behavioral issues. The recommendations as presented here will need to be evaluated for improvements to allow for continued optimization of diagnostics and care.

Identifiants

pubmed: 30677142
doi: 10.1111/cge.13506
doi:

Substances chimiques

Transcription Factor 4 0

Types de publication

Consensus Development Conference Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-478

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Marcella Zollino (M)

Fondazione Policlinico Universitario A.Gemelli, IRCCS, UOC Genetica.
Università Cattolica Sacro Cuore, Istituto di Medicina Genomica, Roma, Italy.

Christiane Zweier (C)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Ingrid D Van Balkom (ID)

Jonx Department of (Youth) Mental Health and Autism, Lentis Psychiatric Institute, Groningen, The Netherlands.
Rob Giel Research Centre, Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands.

David A Sweetser (DA)

Division of Medical Genetics and Metabolism, Massachusetts General Hospital for Children, Boston, Massachusetts.

Joseph Alaimo (J)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

Emilia K Bijlsma (EK)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Jannine Cody (J)

Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, Texas.

Sarah H Elsea (SH)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

Irina Giurgea (I)

Sorbonne Université, INSERM, UMR_S 933, Assistance Publique Hôpitaux de Paris, Département de Génétique Médicale, Hôpital Trousseau, Paris, France.

Marina Macchiaiolo (M)

Rare and Genetic Diseases Unit, Bambino Gesù Children's Hospital, Rome, Italy.

Robert Smigiel (R)

Department of Pediatrics, Division of Pediatrics and Rare Disorders, Wroclaw Medical University, Wroclaw, Poland.

Ronald L Thibert (RL)

Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Ingrid Benoist (I)

Dutch Pitt-Hopkins Syndrome Foundation, Vlaggeschip, Oosterhout, The Netherlands.

Jill Clayton-Smith (J)

Manchester Centre for Genomic Medicine, St Mary's Hospital, and Division of Evolution and Genomic Sciences School of Biological Sciences, University of Manchester, Manchester, UK.

Channa F De Winter (CF)

Organisation for Individuals with Intellectual Disabilities, Trajectum, Zwolle, The Netherlands.

Stijn Deckers (S)

Department of Pedagogical Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.

Anusha Gandhi (A)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

Sylvia Huisman (S)

Department of Pediatrics, Academic Medical Centre, Amsterdam UMC, Amsterdam, The Netherlands.

Dagmar Kempink (D)

Department of Orthopedic Surgery, Sophia Children's Hospital, UMCR, Rotterdam, The Netherlands.

Frea Kruisinga (F)

Department of Pediatrics, Academic Medical Centre, Amsterdam UMC, Amsterdam, The Netherlands.

Vittoria Lamacchia (V)

Department of Medical Genetics, University of Siena, Siena, Italy.

Giuseppe Marangi (G)

Fondazione Policlinico Universitario A.Gemelli, IRCCS, UOC Genetica.
Università Cattolica Sacro Cuore, Istituto di Medicina Genomica, Roma, Italy.

Leonie Menke (L)

Department of Pediatrics, Academic Medical Centre, Amsterdam UMC, Amsterdam, The Netherlands.

Paul Mulder (P)

Jonx Department of (Youth) Mental Health and Autism, Lentis Psychiatric Institute, Groningen, The Netherlands.
Rob Giel Research Centre, Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands.

Ann Nordgren (A)

Karolinska Center for Rare Diseases, Karolinska University Hospital, Stockholm, Sweden.

Alessandra Renieri (A)

Department of Medical Genetics, University of Siena, Siena, Italy.

Sue Routledge (S)

Pitt Hopkins UK, Ilford, UK.

Carol J Saunders (CJ)

Center for Pediatric Genomic Medicine, Children's Mercy Hospital, Kansas City, Missouri.

Agnieszka Stembalska (A)

Department of Genetics, Wroclaw Medical University, Wroclaw, Poland.

Hans Van Balkom (H)

Behavioral Science Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.

Sandra Whalen (S)

Sorbonne Université, INSERM, UMR_S 933, Assistance Publique Hôpitaux de Paris, Département de Génétique Médicale, Hôpital Trousseau, Paris, France.

Raoul C Hennekam (RC)

Department of Pediatrics, Academic Medical Centre, Amsterdam UMC, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH